| STIEFEL LABORATORIES, INC. Patent applications |
| Patent application number | Title | Published |
|---|
| 20110237593 | TOPICAL ANTI-PRURITIC COMPOSITIONS AND METHODS OF ACTION OF SAME - Topical anti-pruritic compositions and methods of using the same to treat pruritus. These anti-pruritic compositions are capable of temporarily or permanently reducing, inhibiting, treating, ameliorating, and/or preventing pruritic skin conditions, as well as other related skin conditions. In a particular aspect, the present formulations provide a quicker and more effective treatment of pruritus than do certain present pruritus-treating compositions. | 09-29-2011 |
| 20110163108 | Container venting disc - A container venting disc is punctuated with gaps around the periphery to allow gases from the interior of the container to vent. An intermediate ridge or layer that abuts or is proximal to the interior edge of the container lip is implemented to prevent the disc from significantly moving laterally and to also center the venting disc within the container mouth. The gap(s) forms a channel in the disc to allow gases to escape between the edge of the container mouth and the container cap. The simplicity of design allows for easy manufacture and simple placement in a container, such as for a jar or bottle. | 07-07-2011 |
| 20110092702 | CRYSTALLINE ANTIFUNGAL COMPOUNDS - Novel crystalline forms of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one, pharmaceutical compositions containing these crystalline forms, methods of using these crystalline forms for treating and/or preventing various microbial and/or fungal infections or disorders, and processes for obtaining these crystalline forms. In particular, the present subject matter relates to the specific crystalline Forms I, II, III, IV, V, and VI of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one. | 04-21-2011 |
| 20100292284 | Talarazole metabolites - Novel metabolites of talarazole of formula (I) have been isolated and characterized, wherein R═H, OH, OSO | 11-18-2010 |
| 20100210571 | TOPICAL FORMULATIONS FOR TREATMENT OF SKIN DISORDERS - Topical compositions and methods of using same for treating skin disorders or conditions comprising a storage-stable mixture of a benzoyl peroxide dispersion, clindamycin or pharmaceutically acceptable salts or esters thereof, and a pharmaceutically acceptable carrier. | 08-19-2010 |
| 20090263447 | Crosslinked hyaluronic acid and process for the preparation thereof - The present invention relates to a crosslinked hyaluronic acid that can be obtained according to a process comprising: (a) activation of a hyaluronic acid, (b) reaction of the activated hyaluronic acid with an oligopeptide- or polypeptide-based crosslinking agent, in a reaction medium adjusted to a pH of from 8 to 12, so as to obtain a crosslinked hyaluronic acid, (c) adjustment of the pH of the reaction medium to a value ranging from 5 to 7, and (d) precipitation of the crosslinked hyaluronic acid from an organic solvent. | 10-22-2009 |
